Synapse - Howard Scher

Results (1133)

Intra-patient genomic heterogeneity of single circulating tumor cells (CTCs) associated to phenotypic CTC heterogeneity in metastatic castrate resistant prostate cancer (mCRPC)

Meeting Abstract

Landers, M.; Greene, S.; Schreiber, N. A.; Rodriguez, A.; Bambury, R. M.; Danila, D. C.; Rathkopf, D. E.; Fleisher, M.; Louw, J.; Jendrisak, A.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Circulating tumor cell (CTC) enumeration in men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide post-chemotherapy (phase 3 AFFIRM study)

Meeting Abstract

Fleisher, M.; Danila, D. C.; Fizazi, K.; Hirmand, M.; Selby, B.; Phung, D.; de Bono, J. S.; Scher, H. I.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591

Meeting Abstract

Feldman, J. L.; Morris, M. J.; Martinez, D. F.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; O'Donoghue, J. A.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

STEAP1 as a predictive biomarker for antibody-drug conjugate (ADC) activity in metastatic castration resistant prostate cancer (mCRPC)

Meeting Abstract

Danila, D. C.; Fleisher, M.; Carrasquillo, J. A.; Gilbert, H.; Morris, M. J.; Bellomo, L. P.; Hendrikx, P. J.; Szafer-Glusman, E.; Herkal, A.; Patel, C.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Genomic characterization of primary and metastatic prostate cancer (PC) using a targeted next-generation sequencing assay

Meeting Abstract

Abida, W.; Curtis, K. R.; Taylor, B. S.; Arcila, M. E.; Brennan, R.; Danila, D. C.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; Solit, D. B.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Predictive biomarkers of sensitivity to androgen receptor signaling (ARS) and taxane-based chemotherapy in circulating tumor cells (CTCs) of patients (pts) with metastatic castration resistant prostate cancer (mCRPC)

Meeting Abstract

Scher, H. I.; Louw, J.; Jendrisak, A.; Bambury, R. M.; Danila, D. C.; Rathkopf, D. E.; Arslan, Z.; Schreiber, N. A.; Lu, D.; Krupa, R.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Radical prostatectomy as a component of multimodal therapy for highly selected M1 prostate cancer patients

Meeting Abstract

O'Shaughnessy, M.; Eastham, J. A.; Bochner, B. H.; Laudone, V. P.; Carver, B. S.; Sjoberg, D.; Scardino, P. T.; Scher, H. I.; Touijer, K. A.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Pathologic correlation of (89)Zr-Df-IAB2M antiprostate-specific membrane antigen (PSMA) minibody in patients with metastatic prostate cancer

Meeting Abstract

Morris, M. J.; Solomon, S. B.; Durack, J. C.; O'Donoghue, J. A.; Lyashchenko, S. K.; Ruan, S. T.; Carrasquillo, J. A.; Lewis, J. S.; Martinez, D. F.; Parada, N. A.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Effects of radium-223 dichloride (Ra-223) with docetaxel (D) versus D on prostate-specific antigen (PSA) and bone alkaline phosphatase (bALP) in patients (pts) with castration-resistant prostate cancer (CRPC) and bone metastases (mets): A phase 1/2a clinical trial

Meeting Abstract

Morris, M. J.; Higano, C. S.; Scher, H. I.; Sweeney, C.; Antonarakis, E. S.; Shevrin, D. H.; Ryan, C. J.; Lorlot, Y.; Fizazi, K.; Pandit-Taskar, N.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Assessment of corticosteroid (CS)-associated adverse events (AEs) with long-term (LT) exposure to low-dose prednisone (P) given with abiraterone acetate (AA) to metastatic castration-resistant prostate cancer (mCRPC) patients (Pts)

Meeting Abstract

Fizazi, K.; Chi, K. N.; de Bono, J. S.; Gomella, L. G.; Miller, K.; Rathkopf, D. E.; Ryan, C. J.; Scher, H. I.; Shore, N. D.; De Porre, P.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save